JP2018518940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018518940A5 JP2018518940A5 JP2017553107A JP2017553107A JP2018518940A5 JP 2018518940 A5 JP2018518940 A5 JP 2018518940A5 JP 2017553107 A JP2017553107 A JP 2017553107A JP 2017553107 A JP2017553107 A JP 2017553107A JP 2018518940 A5 JP2018518940 A5 JP 2018518940A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- acid sequence
- amino acid
- antibody
- antibody according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021083700A JP2021121204A (ja) | 2015-04-08 | 2021-05-18 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
| JP2023116535A JP2023130499A (ja) | 2015-04-08 | 2023-07-18 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562144729P | 2015-04-08 | 2015-04-08 | |
| US62/144,729 | 2015-04-08 | ||
| PCT/US2016/026800 WO2016164835A1 (en) | 2015-04-08 | 2016-04-08 | Humanized influenza monoclonal antibodies and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021083700A Division JP2021121204A (ja) | 2015-04-08 | 2021-05-18 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018518940A JP2018518940A (ja) | 2018-07-19 |
| JP2018518940A5 true JP2018518940A5 (enExample) | 2019-05-16 |
| JP6960856B2 JP6960856B2 (ja) | 2021-11-05 |
Family
ID=55754481
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017553107A Active JP6960856B2 (ja) | 2015-04-08 | 2016-04-08 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
| JP2021083700A Pending JP2021121204A (ja) | 2015-04-08 | 2021-05-18 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
| JP2023116535A Withdrawn JP2023130499A (ja) | 2015-04-08 | 2023-07-18 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021083700A Pending JP2021121204A (ja) | 2015-04-08 | 2021-05-18 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
| JP2023116535A Withdrawn JP2023130499A (ja) | 2015-04-08 | 2023-07-18 | ヒト化インフルエンザモノクローナル抗体およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11135282B2 (enExample) |
| EP (1) | EP3280730B1 (enExample) |
| JP (3) | JP6960856B2 (enExample) |
| KR (1) | KR102668588B1 (enExample) |
| CN (1) | CN107750253B (enExample) |
| AU (2) | AU2016246065B2 (enExample) |
| CA (1) | CA2981969C (enExample) |
| IL (2) | IL254951B (enExample) |
| WO (1) | WO2016164835A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| US20170174751A1 (en) * | 2014-03-19 | 2017-06-22 | Dana-Farber Cancer Institute, Inc. | Immunogenetic restriction on elicitation of antibodies |
| EP3419663A1 (en) | 2016-02-24 | 2019-01-02 | Visterra, Inc. | Formulations of antibody molecules to influenza virus |
| CN110214152B (zh) | 2016-10-14 | 2025-06-13 | 丹娜法伯癌症研究所公司 | 模块化四聚体双特异性抗体平台 |
| SG11202006379UA (en) * | 2018-01-26 | 2020-07-29 | Regeneron Pharma | Human antibodies to influenza hemagglutinin |
| WO2019178356A1 (en) | 2018-03-14 | 2019-09-19 | Dana-Farber Cancer Institute, Inc. | Engineered cells, t cell immune modulating antibodies and methods for using the same |
| JP2021534393A (ja) | 2018-08-13 | 2021-12-09 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 疑似インビボ条件での治療用タンパク質の選択 |
| CN109448781B (zh) * | 2018-11-06 | 2021-09-14 | 云南大学 | 一种流感病毒抗原变化的预测方法 |
| CN111423507B (zh) * | 2019-01-10 | 2022-04-15 | 中国科学院分子细胞科学卓越创新中心 | 广谱性中和流感病毒的全人抗体 |
| CA3132521A1 (en) | 2019-03-25 | 2020-10-01 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| WO2021119467A1 (en) * | 2019-12-11 | 2021-06-17 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| WO2023081471A1 (en) | 2021-11-05 | 2023-05-11 | Dana-Farber Cancer Institute, Inc. | Human broadly crossreactive influenza monoclonal antibodies and methods of use thereof |
| CN114366809B (zh) * | 2022-01-12 | 2024-07-23 | 广州瑞贝斯药业有限公司 | 一种铝纳米晶递送系统及其结合疫苗抗原分子自组装颗粒佐剂疫苗 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| FR2413974A1 (fr) | 1978-01-06 | 1979-08-03 | David Bernard | Sechoir pour feuilles imprimees par serigraphie |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| DE3788058T2 (de) | 1986-08-28 | 1994-04-21 | Teijin Ltd | Zelltoxischer antikörperkomplex und verfahren zu seiner herstellung. |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5091513A (en) | 1987-05-21 | 1992-02-25 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5132405A (en) | 1987-05-21 | 1992-07-21 | Creative Biomolecules, Inc. | Biosynthetic antibody binding sites |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
| EP0479909B1 (en) | 1989-06-29 | 1996-10-30 | Medarex, Inc. | Bispecific reagents for aids therapy |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| ES2284161T3 (es) | 1990-01-12 | 2007-11-01 | Amgen Fremont Inc. | Generacion de anticuerpos xenogenicos. |
| ATE204902T1 (de) | 1990-06-29 | 2001-09-15 | Large Scale Biology Corp | Melaninproduktion durch transformierte mikroorganismen |
| AU8507191A (en) | 1990-08-29 | 1992-03-30 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
| US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
| US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
| US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| WO1992020373A1 (en) | 1991-05-14 | 1992-11-26 | Repligen Corporation | Heteroconjugate antibodies for treatment of hiv infection |
| US5233409A (en) | 1992-02-25 | 1993-08-03 | Schwab Karl W | Color analysis of organic constituents in sedimentary rocks for thermal maturity |
| ES2301158T3 (es) | 1992-07-24 | 2008-06-16 | Amgen Fremont Inc. | Produccion de anticuerpos xenogenicos. |
| DE69303494T2 (de) | 1992-11-13 | 1997-01-16 | Idec Pharma Corp | Therapeutische verwendung von chimerischen und markierten antikörper gegen menschlichen b lymphozyt beschränkter differenzierung antigen für die behandlung von b-zell-lymphoma |
| EP0745134A1 (en) | 1994-02-22 | 1996-12-04 | Danafarber Cancer Institute | Nucleic acid delivery system, method of synthesis and uses thereof |
| EP0822830B1 (en) | 1995-04-27 | 2008-04-02 | Amgen Fremont Inc. | Human anti-IL-8 antibodies, derived from immunized xenomice |
| WO1996034096A1 (en) | 1995-04-28 | 1996-10-31 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US5916771A (en) | 1996-10-11 | 1999-06-29 | Abgenix, Inc. | Production of a multimeric protein by cell fusion method |
| US20020029391A1 (en) | 1998-04-15 | 2002-03-07 | Claude Geoffrey Davis | Epitope-driven human antibody production and gene expression profiling |
| MX2011011331A (es) | 2009-05-11 | 2011-11-18 | Crucell Holland Bv | Moleculas de union humanas capaces de neutralizar el virus de la influenza h3n2 y usos de las mismas. |
| HRP20170490T1 (hr) * | 2010-03-26 | 2017-06-02 | Pomona Ricerca S.R.L. | Imunoglobulini pune dužine igg izotipa sposobni za prepoznavanje heterosubtipnog epitopa neutralizacije na području stabljike hemaglutinina i njihova uporaba kao lijek protiv gripe |
| US9534042B2 (en) * | 2010-09-03 | 2017-01-03 | Fujita Health University | Influenza virus-neutralizing antibody and screening method therefor |
| IN2014CN00953A (enExample) * | 2011-07-14 | 2015-04-10 | Crucell Holland Bv | |
| EP3418300B1 (en) * | 2011-07-18 | 2020-10-28 | Institute for Research in Biomedicine | Neutralizing anti-influenza a virus antibodies and uses thereof |
| JP5998222B2 (ja) * | 2011-09-30 | 2016-09-28 | セルトリオン・インコーポレイテッド | ヒトｂ細胞で生産されたインフルエンザａウイルス中和活性を持つ結合分子 |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| JP6386465B2 (ja) * | 2012-11-13 | 2018-09-05 | ジェネンテック， インコーポレイテッド | 抗ヘマグルチニン抗体及び使用方法 |
| US9111624B2 (en) | 2013-03-22 | 2015-08-18 | Katsuyuki Fujita | Semiconductor memory device |
-
2016
- 2016-04-08 AU AU2016246065A patent/AU2016246065B2/en active Active
- 2016-04-08 WO PCT/US2016/026800 patent/WO2016164835A1/en not_active Ceased
- 2016-04-08 CN CN201680033270.XA patent/CN107750253B/zh active Active
- 2016-04-08 JP JP2017553107A patent/JP6960856B2/ja active Active
- 2016-04-08 EP EP16716806.1A patent/EP3280730B1/en active Active
- 2016-04-08 US US15/564,897 patent/US11135282B2/en active Active
- 2016-04-08 KR KR1020177032200A patent/KR102668588B1/ko active Active
- 2016-04-08 CA CA2981969A patent/CA2981969C/en active Active
-
2017
- 2017-10-09 IL IL254951A patent/IL254951B/en unknown
-
2021
- 2021-05-18 JP JP2021083700A patent/JP2021121204A/ja active Pending
- 2021-08-18 US US17/405,748 patent/US12076390B2/en active Active
- 2021-09-03 AU AU2021225240A patent/AU2021225240A1/en not_active Abandoned
- 2021-09-09 IL IL286208A patent/IL286208A/en unknown
-
2023
- 2023-07-18 JP JP2023116535A patent/JP2023130499A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201975T1 (hr) | Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba | |
| CN111836644A (zh) | 抗密蛋白18.2抗体及其用途 | |
| JP2015503909A5 (enExample) | ||
| JP2020514277A5 (enExample) | ||
| JP2013538057A5 (enExample) | ||
| JP2018064580A5 (enExample) | ||
| JP2018035138A5 (enExample) | ||
| JP2011509245A5 (enExample) | ||
| JP2011505867A5 (enExample) | ||
| JP2017113028A5 (enExample) | ||
| JP2018518540A5 (enExample) | ||
| HRP20120701T1 (hr) | Humana monoklonska protutijela protiv fukozil-gm1 i postupci za uporabu antifukozil-gm1 | |
| RU2019121086A (ru) | Иммунотерапия с применением антител, связывающих лиганд 1 белка программируемой смерти клеток (PD-L1) | |
| JP2019536806A5 (enExample) | ||
| JP2015535691A5 (enExample) | ||
| JP2018506961A5 (enExample) | ||
| JP2017523786A5 (enExample) | ||
| RU2016100892A (ru) | Антитела против tweakr и их применение | |
| JP2014205674A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| JP2017507657A5 (enExample) | ||
| JP2014511179A5 (enExample) | ||
| JP2012525829A5 (enExample) | ||
| JP2018514193A5 (enExample) | ||
| JP2011528901A5 (enExample) |